 | This article needs to be updated. (February 2024) |
| Company type | Privately held company |
|---|---|
| Industry | Biotechnology, Biopharmaceutical industry |
| Founded | 1999 |
| Headquarters | Tartu, Estonia |
Key people | Mart Ustav, CEO |
| Products | Products and services in functional genomics and proteomics, latex allergen tests |
| Services | Certification: ISO 9001:2000 |
| Website |
www |
Quattromed Ltd is one of the leading biotechnology companies in Estonia [1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of March 2009, Icosagen AS is the new business name of the former Quattromed Ltd.
Profile
Quattromed was established in 1999 as a spin-off from Tartu University. [2] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics ( Quattromed HTI Laboratories), life science products ( Quattromed), latex allergen testing (Quattromed Ltd) and protein production ( Quattromed Cell Factory).
Products and services
Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.
Quattromed’s main products are:
- FITkit (latex allergen test) and FITkit testing service [1]
- E2Tag epitope tagging technology [3] [4]
- MAbs to HIV/SIV proteins, epitope tags
- anti-IgG antibodies
- QMCF Technology - a propriety protein production technology (further information)
See also
References
- ^ Frank L. (2001). "Biotechnology in the Baltic". Nature Biotechnology. 19 (6): 513–5. doi: 10.1038/89229. PMID 11385442. S2CID 36541802.
- ^ Estonian Biotechnology Association Archived October 21, 2007, at the Wayback Machine. Retrieved 18. June 2007.
- ^ Kurg R; Parik J; Juronen E; Sedman T; Abroi A; Liiv I; Langel U; Ustav M. (1999). "Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication". Journal of Virology. 73 (6): 4670–7. doi: 10.1128/JVI.73.6.4670-4677.1999. PMC 112508. PMID 10233926.
- ^ Kaldalu N; Lepik D; Kristjuhan A; Ustav M. (2000). "Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags". BioTechniques. 28 (3): 456–60. doi: 10.2144/00283st02. PMID 10723557.
External links
-
Official website
- Icosagen's (formerly Quattromed) FITkit and latex allergen testing
- Icosagen's (formerly Quattromed) life science product catalogue
| This article needs to be updated. (February 2024) |
| Company type | Privately held company |
|---|---|
| Industry | Biotechnology, Biopharmaceutical industry |
| Founded | 1999 |
| Headquarters | Tartu, Estonia |
Key people | Mart Ustav, CEO |
| Products | Products and services in functional genomics and proteomics, latex allergen tests |
| Services | Certification: ISO 9001:2000 |
| Website |
www |
Quattromed Ltd is one of the leading biotechnology companies in Estonia [1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of March 2009, Icosagen AS is the new business name of the former Quattromed Ltd.
Profile
Quattromed was established in 1999 as a spin-off from Tartu University. [2] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics ( Quattromed HTI Laboratories), life science products ( Quattromed), latex allergen testing (Quattromed Ltd) and protein production ( Quattromed Cell Factory).
Products and services
Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.
Quattromed’s main products are:
- FITkit (latex allergen test) and FITkit testing service [1]
- E2Tag epitope tagging technology [3] [4]
- MAbs to HIV/SIV proteins, epitope tags
- anti-IgG antibodies
- QMCF Technology - a propriety protein production technology (further information)
See also
References
- ^ Frank L. (2001). "Biotechnology in the Baltic". Nature Biotechnology. 19 (6): 513–5. doi: 10.1038/89229. PMID 11385442. S2CID 36541802.
- ^ Estonian Biotechnology Association Archived October 21, 2007, at the Wayback Machine. Retrieved 18. June 2007.
- ^ Kurg R; Parik J; Juronen E; Sedman T; Abroi A; Liiv I; Langel U; Ustav M. (1999). "Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication". Journal of Virology. 73 (6): 4670–7. doi: 10.1128/JVI.73.6.4670-4677.1999. PMC 112508. PMID 10233926.
- ^ Kaldalu N; Lepik D; Kristjuhan A; Ustav M. (2000). "Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags". BioTechniques. 28 (3): 456–60. doi: 10.2144/00283st02. PMID 10723557.
External links
-
Official website
- Icosagen's (formerly Quattromed) FITkit and latex allergen testing
- Icosagen's (formerly Quattromed) life science product catalogue